These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18171412)

  • 21. Apocrine ductal carcinoma in situ of the breast presenting as a chronic abscess.
    Kenwright DN; Gaskell D; Wakefield L; Dugan N
    Aust N Z J Surg; 1999 Jan; 69(1):72-5. PubMed ID: 9932930
    [No Abstract]   [Full Text] [Related]  

  • 22. Molecular characterization of apocrine carcinoma of the breast: validation of an apocrine protein signature in a well-defined cohort.
    Celis JE; Cabezón T; Moreira JM; Gromov P; Gromova I; Timmermans-Wielenga V; Iwase T; Akiyama F; Honma N; Rank F
    Mol Oncol; 2009 Jun; 3(3):220-37. PubMed ID: 19393583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Invasive apocrine carcinoma of the breast: clinicopathologic features of 57 patients.
    Tanaka K; Imoto S; Wada N; Sakemura N; Hasebe K
    Breast J; 2008; 14(2):164-8. PubMed ID: 18248561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Lobular carcinoma in situ (LCIS): risk factor and precursor of invasive lobular breast cancer].
    Aulmann S; Penzel R; Schirmacher P; Sinn HP
    Verh Dtsch Ges Pathol; 2007; 91():208-13. PubMed ID: 18314616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Columnar cell lesions of the breast.
    Feeley L; Quinn CM
    Histopathology; 2008 Jan; 52(1):11-9. PubMed ID: 18171413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apocrine cysts of the breast: biomarkers, origin, enlargement, and relation with cancer phenotype.
    Celis JE; Gromov P; Moreira JM; Cabezón T; Friis E; Vejborg IM; Proess G; Rank F; Gromova I
    Mol Cell Proteomics; 2006 Mar; 5(3):462-83. PubMed ID: 16316978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of myoepithelium in apocrine glands of the breast does not necessarily imply malignancy.
    Cserni G
    Histopathology; 2008 Jan; 52(2):253-5. PubMed ID: 18184276
    [No Abstract]   [Full Text] [Related]  

  • 28. The diagnostic utility of EZH2 H-score and Ki-67 index in non-invasive breast apocrine lesions.
    Vougiouklakis T; Belovarac BJ; Lytle A; Chiriboga L; Ozerdem U
    Pathol Res Pract; 2020 Sep; 216(9):153041. PubMed ID: 32825929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The enigmatic nature of apocrine breast lesions.
    Zagorianakou P; Zagorianakou N; Stefanou D; Makrydimas G; Agnantis NJ
    Virchows Arch; 2006 May; 448(5):525-31. PubMed ID: 16570182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic value of silver-stained interphasic nucleolar organizer regions in breast tumors.
    Derenzini M; Betts CM; Trerè D; Mambelli V; Millis RR; Eusebi V; Cancellieri A
    Ultrastruct Pathol; 1990; 14(3):233-45. PubMed ID: 1694051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clonal relationship between closely approximated low-grade ductal and lobular lesions in the breast: a molecular study of 10 cases.
    Wagner PL; Kitabayashi N; Chen YT; Shin SJ
    Am J Clin Pathol; 2009 Dec; 132(6):871-6. PubMed ID: 19926578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of molecular apocrine breast tumours by microarray analysis.
    Farmer P; Bonnefoi H; Becette V; Tubiana-Hulin M; Fumoleau P; Larsimont D; Macgrogan G; Bergh J; Cameron D; Goldstein D; Duss S; Nicoulaz AL; Brisken C; Fiche M; Delorenzi M; Iggo R
    Oncogene; 2005 Jul; 24(29):4660-71. PubMed ID: 15897907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apocrine carcinomas of the breast.
    Page DL
    Breast; 2005 Feb; 14(1):1-2. PubMed ID: 15695073
    [No Abstract]   [Full Text] [Related]  

  • 34. Cytological and biochemical studies of breast cyst fluid.
    Tsung JS; Wang TY; Wang SM; Yang PS
    Breast; 2005 Feb; 14(1):37-41. PubMed ID: 15695079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Papillary lesions of the breast: selected diagnostic and management issues.
    Collins LC; Schnitt SJ
    Histopathology; 2008 Jan; 52(1):20-9. PubMed ID: 18171414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bilateral axillary apocrine nevi--a case report.
    Amonkar GP; Amonkar PP; Rege JD
    Indian J Pathol Microbiol; 2005 Jan; 48(1):22-3. PubMed ID: 16758779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary cutaneous apocrine carcinoma versus metastasis, a plea to the dermatopathology community.
    Fernandez-Flores A
    Am J Dermatopathol; 2010 Dec; 32(8):853-4. PubMed ID: 20431390
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast cancer special types: why bother?
    Reis-Filho JS; Lakhani SR
    J Pathol; 2008 Dec; 216(4):394-8. PubMed ID: 18798222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apocrine cystic metaplasia: subgross pathology and prevalence in cancer-associated versus random autopsy breasts.
    Wellings SR; Alpers CE
    Hum Pathol; 1987 Apr; 18(4):381-6. PubMed ID: 3557440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.